Designing a quality assurance process for quality control of nuclear magnetic resonance metabolomics studies of human blood
NMR in Biomedicine · 2023-04 · 36 (4)
DOI: 10.1002/nbm.4868 ↗Kurz gefasst
Fachartikel in der Zeitschrift NMR in Biomedicine, online erschienen am 12.12.2022. Verfasst von Isabella H Muti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Metabolomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS, NIH HHS.
Abstract (Originalsprache)
High‐resolution magic angle spinning (HRMAS) nuclear magnetic resonance (NMR)‐based metabolomics has demonstrated its utility in studies of biofluids for various diseases. HRMAS NMR spectroscopy is uniquely well suited for analyzing human blood samples because of the small quantity of samples and minimal preparation required. To develop this methodology into standardized clinical protocols, establishment of the method's quality assurance (QA) and evaluations of its quality control (QC) are critical. This study aims to assess the QA/QC measured from human blood specimens in the form of serum and plasma through within‐subject and between‐subject comparisons, as well as stability and consistency comparisons over several freezing–thawing cycles of sample storage conditions, and most importantly, the agreement of pooled control samples against individual samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Leo L Cheng
Förderung
- NCI NIH HHS
- NIA NIH HHS
- NIH HHS
- Massachusetts General Hospital
- National Institutes of Health
Zitieren
APA
Muti, I. H., Gonzalez Sanchez-Dahl, M., Zhong, A. B., Weng, J., Füzesi, M. V., Kivisäkk, P., Hyman, B. T., Arnold, S. E., Feldman, A. S., Mercaldo, N. D., & Cheng, L. L. (2023). Designing a quality assurance process for quality control of nuclear magnetic resonance metabolomics studies of human blood. NMR in Biomedicine, 36(4). https://doi.org/10.1002/nbm.4868
Vancouver
Muti IH, Gonzalez Sanchez-Dahl M, Zhong AB, Weng J, Füzesi MV, Kivisäkk P, et al. Designing a quality assurance process for quality control of nuclear magnetic resonance metabolomics studies of human blood. NMR in Biomedicine. 2023;36(4). doi:10.1002/nbm.4868
BibTeX
@article{Muti2023,
author = {Muti, Isabella H and Gonzalez Sanchez-Dahl, Matteo and Zhong, Anya B and Weng, JianXiang and Füzesi, Mark V and Kivisäkk, Pia and Hyman, Bradley T and Arnold, Steven E and Feldman, Adam S and Mercaldo, Nathaniel D and Cheng, Leo L},
title = {Designing a quality assurance process for quality control of nuclear magnetic resonance metabolomics studies of human blood},
journal = {NMR in Biomedicine},
year = {2023},
volume = {36},
number = {4},
doi = {10.1002/nbm.4868}
}
EUVIMED